Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States
Laura E. Stevens, Guillermo Peluffo, Xintao Qiu, et al.
Cancer Research (2022) Vol. 83, Iss. 2, pp. 264-284
Open Access | Times Cited: 57

Showing 1-25 of 57 citing articles:

The Transcriptional and Epigenetic Landscape of Cancer Cell Lineage Plasticity
Alastair Davies, Amina Zoubeidi, Himisha Beltran, et al.
Cancer Discovery (2023) Vol. 13, Iss. 8, pp. 1771-1788
Closed Access | Times Cited: 49
cAMP-PKA/EPAC signaling and cancer: the interplay in tumor microenvironment
Hongying Zhang, Yongliang Liu, Jieya Liu, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 32
Mechanism insights and therapeutic intervention of tumor metastasis: latest developments and perspectives
Xiaoli Shi, Xinyi Wang, Wentao Yao, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 29
Hallmarks of cancer resistance
Muhammad Tufail, Jia-Ju Hu, Jie Liang, et al.
iScience (2024) Vol. 27, Iss. 6, pp. 109979-109979
Open Access | Times Cited: 18
AKT Blocks SIK1-Mediated Repression of STAT3 to Promote Breast Tumorigenesis
Zicheng Sun, Qiwei Jiang, Bing Gao, et al.
Cancer Research (2023) Vol. 83, Iss. 8, pp. 1264-1279
Open Access | Times Cited: 22
WP1066, a small molecule inhibitor of STAT3, chemosensitizes paclitaxel-resistant ovarian cancer cells to paclitaxel by simultaneously inhibiting the activity of STAT3 and the interaction of STAT3 with Stathmin
Jun Yang, Nanjing Li, Xinyu Zhao, et al.
Biochemical Pharmacology (2024) Vol. 221, pp. 116040-116040
Closed Access | Times Cited: 10
Cancer-associated fibroblasts rewire the estrogen receptor response in luminal breast cancer, enabling estrogen independence
Steven Reid, Jessica Pantaleo, Paulina Bolívar, et al.
Oncogene (2024) Vol. 43, Iss. 15, pp. 1113-1126
Open Access | Times Cited: 8
CD44 and its implication in neoplastic diseases
Yiming Xu, Ziyi Bai, Tianxia Lan, et al.
MedComm (2024) Vol. 5, Iss. 6
Open Access | Times Cited: 7
Modulation of JAK-STAT Signaling by LNK: A Forgotten Oncogenic Pathway in Hormone Receptor-Positive Breast Cancer
José A. López-Mejía, Jessica C. Mantilla-Ollarves, Leticia Rocha‐Zavaleta
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14777-14777
Open Access | Times Cited: 13
TBCRC 039: a phase II study of preoperative ruxolitinib with or without paclitaxel for triple-negative inflammatory breast cancer
Filipa Lynce, Laura E. Stevens, Zheqi Li, et al.
Breast Cancer Research (2024) Vol. 26, Iss. 1
Open Access | Times Cited: 4
Core-shell vector-mediated co-delivery of CRISPR/Cas9 system and hydrophobic drugs against triple-negative breast cancer stem cells
Tong Wang, Tianyi Chen, Dazhao Li, et al.
Journal of Controlled Release (2025) Vol. 378, pp. 1080-1091
Closed Access
Omega-3 fatty acids: molecular weapons against chemoresistance in breast cancer
Vittoria Marchio, Giuseppina Augimeri, Catia Morelli, et al.
Cellular & Molecular Biology Letters (2025) Vol. 30, Iss. 1
Open Access
Advance in identified targets of berberine
Ping‐Hua Sun, Ziyuan Wang, Yinchao Ma, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Targeting the Leukemia Inhibitory Factor/Leukemia Inhibitory Factor Receptor Axis Reduces the Growth of Inflammatory Breast Cancer by Promoting Ferroptosis
Bianca A. Romo, Zenaida Fuentes, Lois Randolph, et al.
Cancers (2025) Vol. 17, Iss. 5, pp. 790-790
Open Access
Liver Metastasis in Cancer: Molecular Mechanisms and Management
Wenchao Xu, Jia Xu, Jianzhou Liu, et al.
MedComm (2025) Vol. 6, Iss. 3
Open Access
CREB: A credible cancer drug target
Jinghui Hong, Yuheng Wu, Mengxin Li, et al.
Journal of Pharmacology and Experimental Therapeutics (2025) Vol. 392, Iss. 4, pp. 103529-103529
Closed Access
Novel insights into taxane pharmacology: an update on drug resistance mechanisms, immunomodulation and drug delivery strategies
Giovanni Luca Beretta, Giuliana Cassinelli, Giacomina Rossi, et al.
Drug Resistance Updates (2025) Vol. 81, pp. 101223-101223
Open Access
The multifaceted role of phosphodiesterase 4 in tumor: from tumorigenesis to immunotherapy
Huimin Ren, Shaohui Zhang, Peiyuan Li
Frontiers in Immunology (2025) Vol. 16
Open Access
Molecular Characteristics of Prognosis and Chemotherapy Response in Breast Cancer: Biomarker Identification Based on Gene Mutations and Pathway
Liyan Li, H Lyu, Qian Chen, et al.
Journal of Breast Cancer (2025) Vol. 28
Open Access
Investigating the Potential Therapeutic Targeting of the JAK-STAT Pathway in Cerebrovascular Diseases: Opportunities and Challenges
Jiawei Wu, Bingxin Wang, Li-Ping Shen, et al.
Molecular Neurobiology (2025)
Closed Access
Expression of DDX49 in breast cancer and its mechanism regulating the proliferation and metastasis of breast cancer cells
Yuanbin Wang, Lijun Yang, Xiangli Li, et al.
Growth Factors (2025), pp. 1-11
Closed Access
Extracellular matrix marker LAMC2 targets ZEB1 to promote TNBC malignancy via up-regulating CD44/STAT3 signaling pathway
Ding Wang, Kailibinuer Keyoumu, Rongji Yu, et al.
Molecular Medicine (2024) Vol. 30, Iss. 1
Open Access | Times Cited: 4
STAT3: Key targets of growth-promoting receptor positive breast cancer
Ruiyuan Jiang, Jiayu Zhu, Huanping Zhang, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4
miRNA‐449c‐5p regulates the JAK‐STAT pathway in inhibiting cell proliferation and invasion in human breast cancer cells by targeting ERBB2
Li Li, Yangqiurong Zhang, Kunxian Yang, et al.
Cancer Reports (2024) Vol. 7, Iss. 2
Open Access | Times Cited: 3
Prevention and Co-Management of Breast Cancer-Related Osteoporosis Using Resveratrol
Christine Meyer, Aranka Brockmueller, Constanze Buhrmann, et al.
Nutrients (2024) Vol. 16, Iss. 5, pp. 708-708
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top